Monday, November 16, 2026

Genetic Makeup Influences Medication Effectiveness, Study Finds

Share

A significant factor that might be overlooked by physicians when prescribing medications is your genetic makeup.

Research released on Wednesday in Science Translational Medicine revealed that almost 25% of study participants had been given medications that could potentially require a different drug or dosage based on their genetic information.

The investigation, conducted by experts at the University of Pittsburgh, analyzed 16 genes that influence the body’s reaction to drugs.

DNA samples from 98,590 individuals involved in the National Institutes of Health’s All of Us Research Program were studied and correlated with their medical histories when accessible.

Each participant possessed at least one genetic variation relevant to how their body reacts to specific medications, with an average of nine variations per participant. Among those whose genetic and clinical information was available, 24.4% had been prescribed at least one medication that, according to genetic guidelines, should have been substituted with a different drug or adjusted in dosage.

Nonetheless, the research did not ascertain whether patients faced side effects or if their medications were less effective due to their genetic characteristics.

The senior author of the study, Dr. Philip Empey, an associate professor at the University of Pittsburgh’s pharmacy school, emphasized that understanding a patient’s genetic profile could minimize the trial-and-error approach often associated with prescribing medications.

“I believe that anything we can do to more accurately predict the right medication and dosage from the outset will significantly lessen that trial-and-error phase,” he stated.

A woman in a medical mask sorts pills on a counter.

A pharmacist organizes medications in a Vancouver pharmacy in October 2022. Genetic differences can influence how patients react to certain medications, possibly necessitating adjustments in dosage or the selection of alternative drugs. (Darryl Dyck/The Canadian Press)

Identifying the appropriate medication

Omeprazole and pantoprazole for treating acid reflux, along with atorvastatin for managing cholesterol, were among the most frequently prescribed medications to participants whose genetic profiles indicated potential modifications in treatment.

Empey pointed out that certain genetic variations could heighten the risk of muscle-related issues for patients using statins like atorvastatin, commonly utilized to lower the likelihood of heart attacks or strokes.

This insight could assist healthcare providers in selecting alternative medications or adjusting the treatment plan.

“It enables clinicians to make more informed choices, such as considering a different cholesterol medication, starting at a lower dose, recognizing the maximum dosage limits, or monitoring specific side effects more closely,” Empey explained.

In some cases, the implications can be even more severe.

For instance, specialists consulted by CBC News indicated that genetic testing can identify patients who are less likely to have a favorable response to clopidogrel (Plavix), a medication prescribed to prevent blood clots following cardiac procedures, allowing for alternative treatments.

A man in a suit and tie sits in a laboratory.

Dr. James Kennedy leads the Tanenbaum Centre for Pharmacogenetics at Toronto’s Centre for Addiction and Mental Health. He notes that genetic testing can guide medication choices, but other factors such as diet, lifestyle, and existing medications must also be considered. (CBC)

A guide, not a certainty

Dr. James Kennedy remarked that the findings of the study were not unexpected, but he was notably impressed by the genetic diversity and representation of individuals of African descent.

Kennedy noted that his team has conducted genetic testing for around 11,000 patients, many of whom had already tried multiple antidepressants without achieving positive results.

Approximately 8% to 10% of individuals metabolize certain commonly prescribed antidepressants at an unusually slow rate, leading to a buildup of the drug and possible side effects, he added.

Kennedy stated that genetic testing is particularly advantageous for patients who may have previously struggled with various medications.

However, he cautioned that DNA testing alone cannot predict a patient’s response to a specific medication. Other factors such as current medications, smoking habits, and diet must also be taken into account.

“We provide a blueprint, outlining certain tendencies, but we also need to discuss all other considerations prior to making a final decision,” he explained.

A 2023 clinical trial in Europe referenced in the study indicated that genetic testing prior to prescribing certain drugs decreased adverse reactions. However, implementing routine testing in Canada poses challenges.

A person in purple gloves points to a small plastic test tube.

A researcher at the University of Calgary displays a diagnostic kit used to detect genetic variations in February 2024. Although such testing could assist physicians in personalizing medications for patients, cost and practical obstacles have restricted its widespread implementation in Canada. (Jeff McIntosh/The Canadian Press)

Challenges in Canada’s Testing Landscape

Dr. Jacob Udell, a cardiologist in Toronto, expressed admiration for the study, particularly for its participant genetic diversity, yet noted that few healthcare providers in Canada or the U.S. regularly test patients for genetic variations that might influence medication metabolism.

“This is certainly not a common practice among frontline clinicians,” he noted.

Udell further explained that for a variety of conditions, doctors can prescribe medications, assess patient responses, and make necessary adjustments, typically without major repercussions. This method can often be more practical than routinely screening for genetic variations.

He also raised concerns about whether widespread testing should be prioritized when Canada’s healthcare system is facing challenges in delivering basic services.

“Our main goal is to ensure everyone has access to a family doctor,” he stated.

In addition to the expense of the tests, Udell highlighted that healthcare providers would require access to genetic testing results and the capability to interpret them effectively.

Empey concurred that implementing routine genetic testing would necessitate substantial investment in training, infrastructure, and new systems for sharing results among healthcare professionals.

“The scientific basis is solid for many medications. The primary concerns around implementation become more related to economics, processes, and education,” he added.

Currently, Empey advises that patients should inquire with their physicians or pharmacists about the potential benefits of genetic testing and share any relevant results with them.

Udell cautioned that private testing may become increasingly accessible to those who can afford it, “but this does not benefit those who cannot pay for the testing.”

Read more

Local News